Gelatin

There is very little information available on the use of plasma substitutes in pregnant women. As with all drugs, the benefits and risks must be assessed. Gelatin may be used in the initial treatment of blood loss during pregnancy where plasma volume replacement is needed.

There is very little information available on the use of plasma substitutes in lactating women. As with all drugs, the benefits and risks must be assessed.

None known.

The major undesirable effect risk associated with succinylated gelatin is that of a severe anaphylactic or anaphylactoid reaction.

A list of rare undesirable effects that have been associated with the administration of gelatin is given beneath;

Rare effects (>1 in 10,000 to <1 in 1,000)

Immune system disorders

Rare: Anaphylactic reaction, Anaphylactoid reaction

Nervous system disorders

Rare: Tremor

Cardiac disorders

Rare: Tachycardia

Vascular disorders

Rare: Hypotension, Hypertension

Respiratory, thoracic and mediastinal disorders

Rare: Wheezing, Dyspnoea, Hypoxia

Skin and subcutaneous disorders

Rare: Urticarial reactions, Sweating

General disorders and administration site reactions

Rare: Chills, Pyrexia